Table. Patient Characteristics and Follow-up Events.
| Patient characteristicsa | Patients, No. (%)b | |||||
|---|---|---|---|---|---|---|
| All (N = 21 070) | URI (n = 7910) | UTI (n = 6297) | Pharyngitis (n = 4691) | Conjunctivitis (n = 1103) | EC (n = 1069) | |
| Age, y | ||||||
| 18-24 | 3016 (14.3) | 688 (8.7) | 1223 (19.4) | 652 (13.9) | 79 (7.2) | 374 (35.0) |
| 25-29 | 3965 (18.8) | 1276 (16.1) | 1246 (19.8) | 908 (19.4) | 164 (14.9) | 371 (34.7) |
| 30-34 | 3945 (18.7) | 1522 (19.2) | 1074 (17.1) | 953 (20.3) | 212 (19.2) | 184 (17.2) |
| 35-39 | 3094 (14.7) | 1269 (16.0) | 752 (11.9) | 783 (16.7) | 199 (18.0) | 91 (8.5) |
| 40-49 | 3666 (17.4) | 1639 (20.7) | 959 (15.2) | 804 (17.1) | 219 (19.9) | 45 (4.2) |
| 50-64 | 2557 (12.1) | 1160 (14.7) | 768 (12.2) | 466 (9.9) | 159 (14.4) | 4 (0.4) |
| 65 and older | 827 (3.9) | 356 (4.5) | 275 (4.4) | 125 (2.7) | 71 (6.4) | 0 |
| Women | 17 014 (80.7) | 5610 (70.9) | 6295 (100.0) | 3263 (69.6) | 777 (70.4) | 1069 (100.0) |
| Men | 4056 (19.3) | 2300 (29.1) | 2 (0.0) | 1428 (30.4) | 326 (29.6) | 0 |
| Race/ethnicity | ||||||
| White | 10 728 (50.9) | 4205 (53.2) | 3230 (51.3) | 2421 (51.6) | 618 (56.0) | 254 (23.8) |
| Black/African American | 1461 (6.9) | 450 (5.7) | 451 (7.2) | 319 (6.8) | 65 (5.9) | 176 (16.5) |
| Hispanic | 4823 (22.9) | 1636 (20.7) | 1461 (23.2) | 1094 (23.3) | 220 (19.9) | 412 (38.5) |
| Asian | 362917.2 | 1427 (18.0) | 1051 (16.7) | 767 (16.4) | 183 (16.6) | 201 (18.8) |
| e-Visit prescribingc | ||||||
| Prescription ordered | 12 986 (61.6) | 5660 (71.6) | 5118 (81.3) | 881 (18.8) | 492 (44.6) | 835 (78.1) |
| After e-visit, 72 h follow-upd | ||||||
| Secure message | 734 (3.5) | 302 (3.8) | 160 (2.5) | 220 (4.7) | 40 (3.6) | 12 (1.1) |
| Any related outpatient visit | 452 (2.1) | 0 | 452 (7.2) | 0 | 0 | 0 |
| Physician office visit | 158 (0.7) | 0 | 158 (2.5) | 0 | 0 | 0 |
| Telephone visit | 289 (1.4) | 0 | 289 (4.6) | 0 | 0 | 0 |
| Video visit | 5 (0.0) | 0 | 5 (0.1) | 0 | 0 | 0 |
| ED visit | 111 (0.5) | 36 (0.5) | 42 (0.7) | 25 (0.5) | 3 (0.3) | 5 (0.5) |
| After e-visit, 7 d follow-upd | ||||||
| Secure message | 957 (4.5) | 381 (4.8) | 241 (3.8) | 268 (5.7) | 50 (4.5) | 17 (1.6) |
| Any related outpatient visit | 2841 (13.5) | 903 (11.4) | 612 (9.7) | 1137 (24.2) | 105 (9.5) | 84 (7.9) |
| Physician office visit | 1440 (6.8) | 337 (4.3) | 267 (4.2) | 758 (16.2) | 43 (3.9) | 35 (3.3) |
| Telephone visit | 1,338 (6.4) | 538 (6.8) | 339 (5.4) | 355 (7.6) | 57 (5.2) | 49 (4.6) |
| Video visit | 63 (0.3) | 28 (0.4) | 6 (0.1) | 24 (0.5) | 5 (0.5) | 0 |
| ED visit | 176 (0.8) | 73 (0.9) | 46 (0.7) | 45 (1.0) | 5 (0.5) | 7 (0.7) |
Abbreviations: EC, emergency contraception; ED, emergency department; URI, upper respiratory infection; UTI, urinary tract infection.
Patient characteristics show demographic characteristics (extracted from the patient’s electronic health record) of patients initiating an e-visit through the patient portal. We used the χ2 test to test for differences in patient characteristics across e-visit concern type at a 2-tailed .05 level of statistical significance.
P < .001 for all differences in patient characteristics by specific e-visit concern type.
e-Visit prescribing shows e-visit concern–related prescription orders linked with the e-visit. Cough suppressants were prescribed for URI (cold, cough, or flu) e-visits, and antibiotics for pharyngitis (sore throat) and UTI.
Post–e-visit follow-ups show further interactions with the health system within 72 hours and within 7 days after an e-visit. ED visits and secure message measures include for any clinical reason within 72 hours or within 7 days after an e-visit. Secure messages for pharyngitis concerns may be generated by strep test follow-up.